What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cardiology
- Myocardial infarction
His main research concerns Internal medicine, Cardiology, Electrocardiography, Left ventricular hypertrophy and Heart disease.
His study looks at the relationship between Internal medicine and fields such as Surgery, as well as how they intersect with chemical problems.
Peter M. Okin studies Cardiology, focusing on ST segment in particular.
Peter M. Okin interconnects Predictive value of tests, QRS complex and valvular heart disease in the investigation of issues within Electrocardiography.
His Left ventricular hypertrophy research incorporates themes from Sudden death, Atenolol, Complication, Ventricular remodeling and Angiotensin II.
Peter M. Okin combines subjects such as Albuminuria, Obesity and Microalbuminuria with his study of Heart disease.
His most cited work include:
- Prognostic value of multidetector coronary computed tomographic angiography for prediction of all-cause mortality. (749 citations)
- Angiogenesis Gene Therapy Phase I Assessment of Direct Intramyocardial Administration of an Adenovirus Vector Expressing VEGF121 cDNA to Individuals With Clinically Significant Severe Coronary Artery Disease (627 citations)
- Prognostic implications of left ventricular hypertrophy. (581 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Cardiology, Left ventricular hypertrophy, Electrocardiography and Blood pressure.
Heart rate, Atrial fibrillation, Myocardial infarction, Stroke and Life study are the core of his Internal medicine study.
His Cardiology study frequently links to adjacent areas such as Atenolol.
His study in Left ventricular hypertrophy is interdisciplinary in nature, drawing from both QRS complex, Losartan, Diabetes mellitus, Albuminuria and Hazard ratio.
The Electrocardiography study combines topics in areas such as Surgery, Predictive value of tests, QT interval, ST depression and Physical exercise.
His work in ST segment covers topics such as Coronary artery disease which are related to areas like Ischemia.
He most often published in these fields:
- Internal medicine (95.34%)
- Cardiology (89.95%)
- Left ventricular hypertrophy (37.75%)
What were the highlights of his more recent work (between 2013-2021)?
- Internal medicine (95.34%)
- Cardiology (89.95%)
- Stroke (12.99%)
In recent papers he was focusing on the following fields of study:
Peter M. Okin mainly focuses on Internal medicine, Cardiology, Stroke, Left ventricular hypertrophy and Atrial fibrillation.
He conducted interdisciplinary study in his works that combined Internal medicine and In patient.
The study incorporates disciplines such as Asymptomatic and Ischemic stroke in addition to Cardiology.
As part of one scientific family, Peter M. Okin deals mainly with the area of Stroke, narrowing it down to issues related to the Confidence interval, and often Odds ratio.
His studies deal with areas such as Life study, Losartan, Renal function, Atenolol and Muscle hypertrophy as well as Left ventricular hypertrophy.
His work deals with themes such as Coronary artery disease and Patent foramen ovale, which intersect with Atrial fibrillation.
Between 2013 and 2021, his most popular works were:
- Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model. (237 citations)
- Assessment of the 12-lead electrocardiogram as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 years of age): a scientific statement from the American Heart Association and the American College of Cardiology. (210 citations)
- Risk of Arterial Thromboembolism in Patients With Cancer (191 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Cardiology
Peter M. Okin focuses on Internal medicine, Cardiology, Stroke, Atrial fibrillation and Electrocardiography.
His Cardiology study combines topics from a wide range of disciplines, such as Lower risk and Left ventricular hypertrophy.
His Left ventricular hypertrophy research is multidisciplinary, relying on both Muscle hypertrophy, Amlodipine and Atenolol.
His Stroke research is multidisciplinary, incorporating perspectives in Prospective cohort study, Surgery, Adverse effect and Cataracts.
His Atrial fibrillation research includes themes of Bradford Hill criteria, Ischemic stroke and Heart rate.
Peter M. Okin studied Electrocardiography and P wave that intersect with Fibrosis and Predictive value of tests.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
